ology and metabolism, 82: PP:407-413.
Baxter JH, Mukerji P, Voss AC, Tisadle MJ, Wheeler KB, attenuation protein degradation and enhancing protein synthesis in skeletal muscle in stressed animal model system. Med Sci Sports Exerc. 2006;
Carlson, C. J. Booth, F. W., and Gordon, S. E. (1999). “Skeletal muscle myostatin mRNA expression is fiber – type specific and increases during hindlimb unloading”. Am J Physiol, 77:PP: 601-606.
Ekaza, J. D. Cabello, G. (2006). “Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathologycal aspects”. Experimental cell research. 312 (13): PP:2401-2414.
Eley HL, Russel ST, Baxter JH, Mukerji P, Tisadle MJ. Signaling pathways initiated by β-hydroxy β- methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachetic stimuli. AM J Physiol Endocrinol Metab. 2007 Oct; 293(4)PP:923-31
Flük M, Hoppeler H (2003). “Molecular basis of skeletal muscle plasticity from gene to form and function”. Rev Physiol Biochem Pharmacol; 146،PP:159-216.
Guyton A.C. (2006). Text book of Medical Physiology; 11th edn. W.B.Saunders, Philadelphia, PA.
Hill, J.J., Qiu, Y., Hewick, R.M. & Wolfman, N.M.(2003). “Regulation of myostatin in vivo by GASP-1: a novel protein with protease inhibitor and follistatin domain. Mol Endocrinol 17,PP: 1144-1154
Hulmi JJ, Ahitainin JP, Kaasalainen T, Pollanen E, HaKinem K, Alen M, Selanne H, Kovanen V, Mero AA (2007). “Post exercise myostatin and activin IIB mRNA levels: effects of strenght training”. Med Sci Sports Exerc. 39 PP: 289-297.
Joulia, D., et al (2006). “Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects”. Experimntal Cell Research.35;PP:312-319.
Kerksick,C.M. Rasmussen,C., et al., (2007). “Impact of differing protein sources and creatin containing nutritional formula after 12 weeks of resistance training”. Nutrition 23, pp:647-654.
Kornasio R, Riedrer I, Butler-Browne G, Mouly V, Uni Z, Halevy O. βhydroxy β- methylbutyrate stimulates myogenic cell proliferation, differentiation and survival via the the MAPK/ERK pathways. Biochim Biophys Acta. 2009 May; 1793(5),pp: 755-763.
Kreamer, W.J . and N.A. Rataness(2004).” Fundamental of resistance training : progression and exercise prescription”, Med Sci Sports Exerc. 36 , pp:674-688.
Lee, S. J. et al (2004). “Regulation of muscle mass by myostatin”. Cell and developmental biology. 20:PP: 61-86.
Ma, K., Mallidis, C., Bhasin, S. et al. (2003). Glucocortioid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol 258, pp: 363-371.
Mataskas A, Friedle A, Hertrampf T, Diel P.(2005). Short- term endurance training results in a muscle – specific decrease of myostatin mRNA content in rats. Acta physiol Scand. pp:183-299.
Nissen S, Abumard N.“ Nutritional role of the leucine metabolite β- hydrox β- methylbutyrate (HMB)”. J Nutr Biochem.1997; 8: 300-11.
Nissen SR, Sharp M, Ray JA, Rathmacher D, Rice JC, Fuller JR,Connelly AS, Abumard N. (1996).“Effects of leucin metabolit betahydroxy beta-methyl butyrate on muscle metabolism during resistance exercise training. J Appl Physiol,81, pp:2095-2140.
Patel , K. Amthor , H. (2005). “The function and strategies of myostatin blocked- new hope for therapies aimed at promoting growth of skeletal muscle”. Neuromusclar Disorders.15;pp:117-126.
Pittler Max H, Ernest Edzard.(2004). Dietary supplements for bodyweight reduction: a systematic review. Am J Clin Nutr. 79 (4), pp: 529-
28 .Roth S.M., et al (2003).“Myostatin gene expression is reduced in human with heavy resistance 8,706-709. strenght training: a brief communication”. Exp Biol Med. Pp:217 -225.
29. Rownalds DS, Thmson JS, Effects of β-hydroxy β-methylbutyrate (HMB) supplementation during resistance training on strenght, body composition and muscle damage in trained and untrained young men: A meta-analysis J Strenght Con Res. 2009 May; 23(3), pp:836-46.
30.Saremi,A., Gharakhanloo, R., Sharghi, S., Gharaati, M.R., Larijani, B. Omidfar, K.(2010). “Effects of oral creatine and resistance training on serum myostatin and GASP-1. Molecular and Cellular Endocrinology; 317, pp: 25-30.
31.Slater GJ, Jenkins D. (2000). “β-hydroxy β- methylbutyrate (HMB) supplementation and th promotion of muscle growth and streghnt”. Sports Med. Aug; 30 (2), pp: 105-16.
32. Smith HJ, Mukerji P, Tisadle MJ.” Attenuation of proteasome-induced proteolysisin skeletal muscle by β-hydroxy β- methylbutyrate in cancerinduced muscle loss”. Cancer Res. 2005 Jan; 65(1),pp: 277-83.
33.Thomson JS. “β-hydroxy β- methylbutyrate (HMB) supplementation of resistance trained men”. Asia Pac J Clin Nutr. 2004; 133(supl)pp: 59 -65.
34.Van Koevering MT, Dolezal HG, Gill DR, Owens DR, Strasia FN, Buchanan CA, et al. Effects of β-hydroxy β- methylbutyrate on performance and carcass quality of feedlot steers. J anima sci 1994 Aug; 72(8), pp:1927-35.
35.Walker K.S., Kambadur,R., Sharma, M. & Smith, H.k. (2004). “Resistance training alters plasma myostatin but not IGF-1 in healthy men”. Med Sci Sports Exerc. 36,pp: 787-793.
Walsh, F. S., Celeste, AJ (2005). “Myostatin: a modulator of skeletal muscle stem cells”. Biochemical society transactions. 33(6): PP:1513-7.
Wehling, M. Cai, B. and Tidball, J. G. (2000). “Modulation of myostatin expression during modified muscle use”. FASEB J, 14: PP:103-110.
Whitemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, etal. “Inhibition of myostatin in adult mice increases skeletal muscle mass and strength”. Biochem Biophys Res Commun. 2003 Jan 24;300(4),pp:965-71.
39.Willoghby, D.S. Taylor,I. (2004). “Effects of concentric and eccentric muscle action on serum myostatin and follistatin-like related gene levels”. J Sports Sci and Med.36, pp:226-233.
40.Willoghby, D.S. (2004). “Effects of heavy resistance training on myostatin mRNA and protein expression”. Med Sci Sports Exerc. 36, 574-582.
41.Willoughby. DS.(2004). “Effects of an alleged myostatin-binding supplement and heavy resistance training on serum myostatin, muscle strength and mass, and body composition”. Int J Sport Nutr Exerc Metab.
2004 Aug;14(4), pp: 461-72.